Library

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1435-1803
    Keywords: Key words Glucocorticoids – human smooth muscle cells – neutral endopeptidase – protein kinase C
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Neutral endopeptidase 24.11 (NEP) degrades vasoactive peptides, including natriuretic peptides, kinins, angiotensins, and endothelins. It contributes to the regulation of vascular tone and body fluid homeostasis. In the present study the expression of NEP was investigated in cultured human smooth muscle cells derived from umbilical veins (HSMC) and human coronary arteries (HCSMC). A constitutive NEP expression was found in growing and starved smooth muscle cells and was about 4 fold higher than in endothelial cells derived from umbilical veins. Treatment of smooth muscle cells with dexamethasone (0.01–0.1 μM Dex) and with the protein kinase C activator, phorbol myristate acetate (0.1 μM PMA), increased NEP mRNA by 3–4 fold and two fold, respectively. Dexamethasone (0.1 μM) and prednisolone (0.1 μM) increased protein concentrations of NEP and NEP‐activity after 3 days and continued to increase at 5 days, whereas PMA induced maximal increase of NEP concentrations after 48 hours. The effect of dexamethasone was concentration‐dependent and was comletely abolished by cycloheximide (10 μM), a protein synthesis inhibitor. The effect of PMA on NEP protein was completely blocked by protein kinase C inhibitors, calphostin C and H7 (both 10 μM). NEP 24.11 is constitutively expressed in human smooth muscle cells from unbilical veins and coronary arteries and is upregulated by glucocorticoids and by protein kinase C activation in these cells.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...